Bibliografía del artículo
1. Gontijo CM, da Silva ES, de Fuccio MB, de Sousa MC, Pacheco RS, Dias ES, et al.
Epidemiological studies of an outbreak of cutaneous leishmaniasis in the Rio
Jequitinhonha Valley, Minas Gerais, Brazil. Acta Trop 81:143-50, 2002.
2. Musa AM, Noazin S, Khalil EAG, Modabber F. Immunological stimulation for the treatment
of leishmaniasis: a modality worthy of serious consideration. Trans R Soc Trop
Med Hyg 104:1-2, 2009.
3. Mayrink W, Botelho ACC, Magalhães PA, Batista SM, Lima AOl, Genaro O, et al.
Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous
leishmaniasis treatment. Rev Soc Bras Med Trop 39:14-21, 2006.
4. Botelho ACC, Mayrink W, Oliveira RC. Alterations in phenotypic profiles of peripheral
blood cells from patients with human American cutaneous leishmaniasis following
treatment with an antimonial drug and a vaccine. Acta Trop 112:143-8, 2009.
5. Ventakaram M, Moosa M, Devi L. Histopathological spectrum in cutaneous leishmaniasis:
A study in Oman. Indian J Dermatol Venereol Leprol 67:294-8, 2001.
6. ul Bari A, ber Rahman S. Correlation of clinical, histopathological and microbiological
findings in 60 cases of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 72:28-32, 2006.
7. Reis LC, Brito MEF, Souza MA, Medeiros AC, Silva CJ, Luna CF, et al. Cellular immune
response profile in patients with american tegumentary leishmaniasis prior and post chemotherapy treatment. J Clin Lab Anal 23:63-9, 2009.
8. Castellano RL, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, et al. Th1/Th2
immune responses are associated with active cutaneous leishmaniasis and clinical
cure is associated with strong interferon production. Hum Immunol 70:383-90, 2009.
9. Meymandi S, Dabiri S, Meymandi-Shamsi M, Nikpour H, Kharazmi A.
Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis.
Arch Iranian Med 12:371-6, 2009.
10. Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, et al.
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated
inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect immune 73:7853-9, 2005.
11. Vieira MG, Oliveira F, Arruda S, Bittencourt AL, Barbosa AA Jr, Barral-Netto M, et al.
B-cell infiltration and frequency of cytokine producing cells differ between localized and disseminated human cutaneous leishmaniases. Mem Inst Oswaldo Cruz 97:979-83, 2002.
12. Amato VS, de Andrade HF, Duarte MI. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 85:39-49, 2003.